The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s biosurgery market report forecasts the biosurgery market size to grow to $18.83 Billion by 2027, with a CAGR (compound annual growth rate) of more than 7%.

Learn More On The Biosurgery Market Report 2023 – https://www.thebusinessresearchcompany.com/report/biosurgery-global-market-report

Biosurgery Market Size Forecast
The global biosurgery market is expected to grow from $12.97 billion in 2022 to $14.10 billion in 2023 at a compound annual growth rate (CAGR) of 8.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global biosurgery market size is expected to reach $18.83 billion in 2027 at a CAGR of 7.4%.

North America held the largest biosurgery market share, and Asia-Pacific was the fastest-growing region in 2022.

Key Biosurgery Market Driver ­– Increase In The Prevalence Of Chronic Disease
According to a study report released by the American Action Forum in September 2020, chronic illness frequency and costs are increasing in the United States. Chronic illness is expected to rise further as the sickness rate among children and adolescents rises. Chronic illness is a significant healthcare concern since it costs the United States $3.7 trillion per year, or nearly 19.6% of GDP, and is on the rise. As a result, the rising prevalence of chronic disease is propelling the biosurgery industry forward.

Request for A Sample Of The Global Biosurgery Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9380&type=smp

Key Biosurgery Market Trend – Product Innovations
Major biosurgery firms are introducing new advancements in order to strengthen their market position. Aroa Biosurgery, a New Zealand-based developer of medical and surgical devices, for example, developed Myriad MorcellsTM in April 2021, a Myriad MatrixTM morcellized (powder) structure that quickly adapts to increase interaction with uneven wound beds. To ‘kick start’ healing, it delivers a burst of biologically relevant ECM proteins in a format tailored to the circumstances of a wound. Myriad MatrixTM is a multi-layered extracellular matrix (ECM) graft with a high volume and surface area that has interstitial spaces that are immediately and easily accessible to cells. It employs the Aroa ECMTM bioscaffold technology, which includes critical secondary chemicals and residual vascular pathways to aid in the development of new tissue.

Biosurgery Market Segment
1) By Product: Bone-Graft Substitutes, Soft-Tissue Attachments, Hemostatic Agents, Surgical Sealants and Adhesives, Adhesion Barriers, Staple Line Reinforcement
2) By Source: Natural or Biologics Products, Synthetic Products
3) By Application: Orthopedic Surgery, General Surgery, Neurological Surgery, Cardiovascular Surgery, Gynecological Surgery, Other Applications4) By End-User: Hospitals, Clinics, Other End-Users

Biosurgery Market Major Players and Strategies
Major players in the biosurgery market are Baxter International Inc., B. Braun SE, Becton, Dickinson and Company, Hemostasis LLC, Integra LifeSciences Corporation, Medtronic Plc, Johnson & Johnson Services Inc., Stryker Corporation, CSL Limited, Pfizer Inc., CryoLife Inc., Aroa Biosurgery Limited, Tissue Regenix, Smiths & Nephew Plc., C.R. Bard, Zimmer Biomet, Kuros Biosciences AG, and Orthofix Medical Inc.

Becton, Dickinson (BD) and business, a US-based medical technology business, acquired Tissuemed Ltd. for an undisclosed sum in December 2021. BD would be able to significantly reinforce Tissuemed’s position as a leader in the rapidly increasing global market for sealant technology with this purchase. Tissuemed is a medical technology firm established in the United Kingdom that creates tissue-based therapeutic devices and bioadhesive films for use in biosurgery.

The Biosurgery Global Market Report 2023 covers regional data on biosurgery market size, biosurgery market trends and drivers, opportunities, strategies, and biosurgery market competitor analysis. The countries covered in the biosurgery market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Biosurgery is the use of live maggots to remove dead tissue from wounds, lower the risk of infection, and accelerate wound healing. It is made up mostly of semi-synthetic, synthetic, or natural elements that aid in the healing of surgical incisions and tissue restoration.

View More Reports Related To The Biosurgery Market –
Cardiovascular Surgery Devices And Equipment Global Market Report 2023
Cataract Surgery Devices And Equipment Global Market Report 2023
Spinal Surgery Devices And Equipment Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: